PRDM16 and neoplasm: To substantiate this finding, we analyzed Prdm16 expression by immunohistochemistry (IHC) using large human tissue microarrays (TMAs) comprising samples with tumor lesions at various stages (e.g., PanIN1, PanIN2, PanIN3, PDAC) and normal tissues.